Bg pattern

MEDSAMIC 100 mg/mL Injectable Solution

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MEDSAMIC 100 mg/mL Injectable Solution

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Medsamic 100 mg/ml Solution for Injection EFG

tranexamic acid

Read this package leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Medsamic and what is it used for
  2. What you need to know before you use Medsamic
  3. How to use Medsamic
  4. Possible side effects
  5. Storage of Medsamic

Contents of the pack and further information

1. What is Medsamic and what is it used for

Medsamic solution for injection contains tranexamic acid, which belongs to a group of medicines called antihemorrhagics, antifibrinolytics, amino acids.

This medicine is used in adults and children over 1 year of age to prevent and treat bleeding due to a process that inhibits blood coagulation called fibrinolysis.

The specific indications include the following:

  • Heavy menstrual bleeding in women
  • Gastrointestinal bleeding
  • Hemorrhagic disorders of the urinary tract, after prostate surgery or surgical procedures that affect the urinary tract
  • Ear, nose, or throat surgery
  • Cardiac, abdominal, or gynecological surgery

Bleeding after treatment with another medicine to dissolve blood clots.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Medsamic

Do not use Medsamic:

  • If you are allergic to tranexamic acid or any of the other ingredients of this medicine (listed in section 6)
  • If you currently have a disease that leads to blood clots
  • If you have a condition called "consumption coagulopathy" where the blood throughout the body starts to clot
  • If you have kidney problems
  • If you have a history of seizures.

Due to the risk of cerebral edema and seizures, intrathecal and intraventricular injection and intracerebral application are not recommended.

If you think any of these situations apply to you, or if you have any doubts, talk to your doctor before using this medicine.

Warnings and precautions

Talk to your doctor before you start using Medsamic.

Tell your doctor if you are in any of these situations to help them decide if Medsamic is suitable for you:

  • If you have had blood in your urine, this could lead to obstruction of the urinary tract.
  • If you are at risk of forming blood clots.
  • If you suffer from excessive clotting or bleeding in the body (disseminated intravascular coagulation), this medicine may not be suitable for you, unless you have acute severe bleeding and blood tests show that the process that inhibits blood coagulation called fibrinolysis has been activated.
  • If you have had seizures, tranexamic acid should not be administered. Your doctor should use the lowest possible dose to avoid seizures after treatment with this medicine.
  • If you are on long-term treatment with this medicine, attention should be paid to possible changes in color vision, and if necessary, treatment should be discontinued. With the long-term use of this medicine, periodic ophthalmological examinations (eye exams, such as visual acuity, color vision, fundus examination, visual field, etc.) are indicated. In the event of pathological eye changes, especially retinal diseases, your doctor should decide, after consulting with a specialist, on the need for long-term use of this medicine in your case.

Other medicines and Medsamic

Tell your doctor, nurse, or pharmacist if you are taking, have recently taken, or might take any other medicines.

Specifically, you should tell them if you use:

  • other medicines that help blood to clot, called antifibrinolytics
  • medicines that prevent blood from clotting, called thrombolytics
  • oral contraceptives.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Tranexamic acid is excreted in breast milk, therefore, the use of this medicine is not recommended during breastfeeding.

Driving and using machines

No studies have been performed on the ability to drive and use machines.

3. How to use Medsamic

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.

Use in adults

The Medsamic solution for injection will be administered to you by slow injection into a vein.

Your doctor will decide the correct dose for you and for how long you should receive it.

Use in children

If this medicine is given to a child over 1 year of age, the dose should be based on the child's weight. The doctor will decide the correct dose for the child and for how long they should receive it.

Use in elderly patients

No dose reduction is necessary unless there are signs of renal insufficiency.

Use in patients with kidney problems

If you have kidney problems, the dose of tranexamic acid will be reduced according to the results of a blood test (serum creatinine level).

Use in patients with liver insufficiency

No dose reduction is necessary.

Method of administration

This medicine should only be administered slowly into a vein.

This medicine should not be injected into a muscle.

If you use more Medsamic than you should

If you have received a higher dose of Medsamic than recommended, you may experience a temporary drop in blood pressure. Talk to your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, talk to your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The side effects reported with tranexamic acid are as follows:

Common (may affect up to 1 in 10 people)

  • Gastrointestinal effects: nausea, vomiting, diarrhea.

Uncommon (may affect up to 1 in 100 people)

  • Skin effects: rash.

Frequency not known (cannot be estimated from the available data)

  • Discomfort with hypotension (low blood pressure), with or without loss of consciousness, especially after a too rapid intravenous injection
  • Blood clots
  • Nervous system effects: seizures
  • Eye effects: vision disorders including color vision impairment
  • Immune system effects: allergic reactions.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible that they are not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Medsamic

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the label after "EXP". The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Medsamic

  • The active substance is tranexamic acid.

Each 1 ml of solution contains 100 mg of tranexamic acid.

Each 5 ml ampoule contains 500 mg of tranexamic acid.

Each 10 ml ampoule contains 1000 mg of tranexamic acid.

  • The other ingredients are: water for injections.

Appearance and packaging

5 ml glass ampoules type I. Boxes of 5 ampoules x 5 ml.

10 ml glass ampoules type I. Boxes of 5 ampoules x 10 ml.

5 ml glass ampoules type I. Boxes of 10 ampoules x 5 ml.

10 ml glass ampoules type I. Boxes of 10 ampoules x 10 ml.

Not all pack sizes may be marketed.

Marketing authorization holder

Medochemie Limited

1-10 Constantinoupoleos Street

3011 Limassol

Cyprus

Manufacturer

Medochemie Ltd. - Ampoule Injectable Facility

48 Iapetou Street, Agios Athanassios Industrial Area

4101 Limassol

Cyprus

You can ask for more information about this medicine from the local representative of the marketing authorization holder:

Local representative:

Medochemie Iberia S.A., Sucursal en España

Avenida de las Águilas, nº 2 B; planta 5 oficina 6,

28044 Madrid

SPAIN

Date of last revision of this package leaflet: 01/2022

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for MEDSAMIC 100 mg/mL Injectable Solution

Discuss questions about MEDSAMIC 100 mg/mL Injectable Solution, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for MEDSAMIC 100 mg/mL Injectable Solution?
MEDSAMIC 100 mg/mL Injectable Solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MEDSAMIC 100 mg/mL Injectable Solution?
The active ingredient in MEDSAMIC 100 mg/mL Injectable Solution is tranexamic acid. This information helps identify medicines with the same composition but different brand names.
How much does MEDSAMIC 100 mg/mL Injectable Solution cost in pharmacies?
The average pharmacy price for MEDSAMIC 100 mg/mL Injectable Solution is around 8.24 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures MEDSAMIC 100 mg/mL Injectable Solution?
MEDSAMIC 100 mg/mL Injectable Solution is manufactured by Medochemie Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MEDSAMIC 100 mg/mL Injectable Solution online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MEDSAMIC 100 mg/mL Injectable Solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MEDSAMIC 100 mg/mL Injectable Solution?
Other medicines with the same active substance (tranexamic acid) include TRANEXAMIC ACID APC INSTYTUT 500 mg FILM-COATED TABLETS, TRANEXAMIC ACID BAXTER 100 mg/mL INJECTABLE SOLUTION, TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media